FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064159 [Registered on: 14/03/2024] Trial Registered Prospectively
Last Modified On: 14/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized Factorial Trial 
Public Title of Study   Prospective Study Comparing the efficacy of Intrathecal Hyperbaric Bupivacaine(0.5%) 3.5ml, Hyperbaric Levobupivacaine(0.5%) 3.5ml and Hyperbaric Ropivacaine(0.75%) 3.5ml in Patients Undergoing Proximal Femoral Nailing Surgery in IQ City Medical College and Hospital, Durgapur 
Scientific Title of Study   Prospective Study Comparing the efficacy of Hyperbaric Bupivacaine, Hyperbaric Levobupivacaine and Hyperbaric Ropivacaine in Patients Undergoing Proximal Femoral Nailing Surgery in IQ City Medical College and Hospital, Durgapur 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  ATREYI BARUA 
Designation  POST GRADUATE TRAINEE 
Affiliation  IQ CITY MEDICAL AND HOSPITAL 
Address  Department of Anaesthesia,IQ CITY MEDICAL COLLEGE, SOVAPUR, JAYMUA DURGAPUR, DIST-PASCHIM BARDHAMAN, WEST BENGAL-713206
Department of Anaesthesia, IQ CITY MEDICAL COLLEGE, SOVAPUR, JAYMUA DURGAPUR, DIST-PASCHIM BARDHAMAN, WEST BENGAL-713206
Barddhaman
WEST BENGAL
713206
India 
Phone  08159844732  
Fax    
Email  atreyibarua@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Susmita Dutta 
Designation  POST GRADUATE TRAINEE 
Affiliation  IQ CITY MEDICAL AND HOSPITAL 
Address  IQ CITY HEALTH CAMPUS, SOVAPUR, JAYMUA DURGAPUR, IQ City Residency, Flat-MC4/GC, DIST-PASCHIM BARDHAMAN, WEST BENGAL-713206
IQ CITY HEALTH CAMPUS, SOVAPUR, JAYMUA DURGAPUR, DIST-PASCHIM BARDHAMAN, WEST BENGAL-713206
Barddhaman
WEST BENGAL
713206
India 
Phone  08159844732  
Fax    
Email  susmita782@gmail.com  
 
Details of Contact Person
Public Query
 
Name  ATREYI BARUA 
Designation  POST GRADUATE TRAINEE 
Affiliation  IQ CITY MEDICAL AND HOSPITAL 
Address  IQ CITY HEALTH CAMPUS, SOVAPUR, JAYMUA DURGAPUR, Department of Anesthesia, 2nd Floor, Room-26, DIST-PASCHIM BARDHAMAN, WEST BENGAL-713206
IQ CITY HEALTH CAMPUS, SOVAPUR, JAYMUA DURGAPUR, DIST-PASCHIM BARDHAMAN, WEST BENGAL-713206
Barddhaman
WEST BENGAL
713206
India 
Phone  08159844732  
Fax    
Email  atreyibarua@gmail.com  
 
Source of Monetary or Material Support  
IQ CITY MEDICAL COLLEGE AND HOSPITAL, DEPARTMENT OF ANAESTHESIOLOGY,DEPARTMENT OF ANAESTHESIOLOGY, JAYMUA, DURGAPUR, WEST BENGAL-713206 
 
Primary Sponsor  
Name  IQ CITY MEDICAL COLLEGE 
Address  IQ CITY HEALTH CAMPUS, JAUMUA, BIJRA ROAD, DUGAPUR, WEST BENGAL-713206 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR ATREYI BARUA  IQ CITY MEDICAL COLLEGE AND HOSPITAL, Department of Anesthesia, 2nd floor, Room no-26  IQ CITY HEALTH CAMPUS, JAYMUA, BIJRAROAD, DURGAPUR, PASCHIM BARDHAMAN, WEST BENGAL-713206
Barddhaman
WEST BENGAL 
8159844732

atreyibarua@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTE, IQ CITY MEDICAL COLLEGE AND HOSPITAL  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S721||Pertrochanteric fracture, (2) ICD-10 Condition: S721||Pertrochanteric fracture, (3) ICD-10 Condition: S721||Pertrochanteric fracture,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1.FIRST AGENT-INTRATHECAL HYPERBARIC BUPIVACAINE(0.5%)-3.5ml Intrathecally  1.INTATHECAL HYPERBARIC BUPIVACAINE(0.5%)-IT WILL GIVE IN 3.5 ML DURING SPINAL ANAESTHESIA INTRATHECALY IN PATIENT PRESENTED POSTED FOR PROXIMAL FEMORAL NAILING SURGERY TO COMPARE THERE EFFICACY AND HEMODYNAMIC STABILITY. ONSET OF MOTOR BLOCK WILL ASSESS BY MODIFIED BROMAGE SCALE AND ONSET OF SENSORY BLOCK WILL ASSESS BY PIN PRICK METHOD AND DURATION OF MOTOR AND SENSORY BLOCK WILL ASSESS. VITALS WERE TAKEN PREOPERATIVELY, AFTER SAB, INTRAOPERATIVELY AND POST OPERATIVELY.ITS A HYPERBARIC SOLUTION AS IT CONTAIN GLUCOSE(80 MG/ML). ITS A AMIDE GROUP LONG ACTING LOCAL ANAESTHETIC AGENTS.  
Comparator Agent  2.INTRATHECAL HYPERBARIC LEVOBUPIVACAINE(0.5%)-3.5ml Intrathecally  2.INTRATHECAL HYPERBARIC LEVOBUPIVACAINE(0.5%)-IT WILL GIVE IN 3.5 ML DURING SPINAL ANAESTHESIA INTRATHECALY IN PATIENT PRESENTED POSTED FOR PROXIMAL FEMORAL NAILING SURGERY TO COMPARE THERE EFFICACY AND HEMODYNAMIC STABILITY. ONSET OF MOTOR BLOCK WILL ASSESS BY MODIFIED BROMAGE SCALE AND ONSET OF SENSORY BLOCK WILL ASSESS BY PIN PRICK METHOD AND DURATION OF MOTOR AND SENSORY BLOCK WILL ASSESS. VITALS WERE TAKEN PREOPERATIVELY, AFTER SAB, INTRAOPERATIVELY AND POST OPERATIVELY.ITS ALSO A LOCAL ANAESTHETICS CONTAIN GLUUCOSE (80 MG/ML) AND MAKE IT HYPERBARIC. ITS A ENANTIOMER OF BUPIVACAINE. ITS ALSO LOCAL ANAESTHETICS.  
Comparator Agent  3.INTRATHECAL HYPERBARIC ROPIVACAINE (0.75%)-3.5ml Intrathecally  3.INTRATHECAL HYPERBARIC ROPIVACAINE (0.75%)- IT WILL GIVE IN 3.5 ML DURING SPINAL ANAESTHESIA INTRATHECALLY IN PATIENT PRESENTED POSTED FOR PROXIMAL FEMORAL NAILING SURGERY TO COMPARE THERE EFFICACY AND HEMODYNAMIC STABILITY. ONSET OF MOTOR BLOCK WILL ASSESS BY MODIFIED BROMAGE SCALE AND ONSET OF SENSORY BLOCK WILL ASSESS BY PIN PRICK METHOD AND DURATION OF MOTOR AND SENSORY BLOCK WILL ASSESS. VITALS WERE TAKEN PREOPERATIVELY, AFTER SAB, INTRAOPERATIVELY AND POST OPERATIVELY.THIS ALSO CONTAIN GLUCOSE (80 MG/ML) FOR MAKING IT HYPERBARIC. ITS A LONG ACTING AMIDE GROUP LOCAL ANAESTHETICS. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  INCLUSION CRITERIA:
(i) ASA physical status 1 and 2
(ii) Patient Age 18-65 years.
(iii) Both male and female
 
 
ExclusionCriteria 
Details  EXCLUSION CRITERIA:
A. Patient refusal
B. ASA physical status 3 and 4
C. Immunocompromised patients
D. Local site infection
E. Known allergy to local Anaesthesia
F. Patient’s on anticoagulants medications

 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
onset and duration of motor and senosry block and hemodynamic stability of three drugs will compare.  onset and duration of motor and senosry block and hemodynamic stability of three drugs will compare at Day 1, 4 weeks and 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Hemodynamic stability of three drugs will compare.  onset & duration of motor & senosry block & hemodynamic stability of three drugs will compare at day 1, 4 weeks & 8 weeks 
 
Target Sample Size   Total Sample Size="75"
Sample Size from India="75" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   24/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   “Prospective Study Comparing the Efficacy of Hyperbaric Bupivacaine, Hyperbaric     Levobupivacaine and Hyperbaric Ropivacaine in Patients Undergoing Proximal Femoral Nailing Surgery in IQ City Medical College, Durgapur’’


Ø OBJECTIVES OF RESEARCH:

      GENERAL OBJECTIVE

a.     To compare the intraoperative hemodynamic stability of the three agents and their side effects.

         SPECIFIC OBJECTIVE

a.     To compare the onset of motor and sensory block of three agents.

b.     To compare the duration of motor and sensory block of three agents.

c.     To compare the regression of motor and sensory block of three agents.

 


Ø METHODOLOGY:

     

STUDY   TYPE:  Prospective interventional study

 

STUDY DESIGN:  Randomized and double blinded study

 

STUDY AREA:  The study will be conducted in IQ City Medical College and   

                                Hospital, Durgapur, West Bengal.

 

TIME PERIOD:

Study will be conducted for one year period from November 2022 to October 2023. The first 9 months will be used data collection and the last 3 months will be utilised for data analysis and writing of the thesis.

 

 STUDY POPULATION: 

All adult patients aged between 18-65 years who will be undergoing proximal femur nailing surgery under spinal anaesthesia.

 

 

 

 

 

 

 

SAMPLE SIZE:

Assuming p value less than 0.05 to be significant and considering effect to be two sided we get

 ð‘ð›¼ =1.96; assuming power of our study to be 80% we get 𝑍1−𝛽 = 0.84; considering an effect size (D = difference between the mean of Time (min) for the transition from Bromage score 3) of 4 (from previous study: Spinal anaesthesia: Comparison of plain ropivacaine, bupivacaine and levobupivacaine for lower abdominal surgery) we get the sample size

     

       n ≥ 2 ∗ (𝑍𝛼 +𝑍1−𝛽)2 ∗ 𝑆𝐷2

                                 D2

 where SD is the pooled standard deviation.

Thus, we have to take at least 25 patients in each group.

 

Group A (n = 25) – will receive 0.5% Hyperbaric Bupivacaine

Group B (n = 25) – will receive 0.5% Hyperbaric Levobupivacaine

Group C (n = 25) – will receive 0.75% Hyperbaric Ropivacaine

 

 

SAMPLING DESIGN: Simple random sampling

 

DATA COLLECTION AND INTERPRETATION:

·       The study will be conducted after patient allocation and getting permission from Institutional Ethics Committee and approved of the West Bengal University of Health Sciences.

·       We are using three drugs Hyperbaric Bupivacaine, Levobupivacaine, Ropivacaine which are Drug Controller General of India (DCGI) approved.

·       Patient aged between 18 to 65 years of physical status ASA grade 1,2 of either sex, undergoing proximal femur nailing surgery will be included in the study.

·       Preoperative evaluation of the patient will be done on the day before surgery and after explaining the procedure written and informed consent will be obtained.

·       On arrival in the anaesthetic room, routine monitoring with ECG, non-invasive arterial pressure and pulse oximetry will commence and venous access will be secured and an infusion of 500ml Ringer’s Lactated will be started. Spinal anaesthesia will be given in the sitting position using a mid-line approach at third lumbar interspace, that is between L3 and L4. A 25g Quincke needle will be inserted with the distal end facing laterally and the appropriate anaesthetic solution will be injected over 10-15sec.

·       Group A will receive 0.3 mg/kg of Hyperbaric Bupivacaine 0.5%, Group B will receive 0.3 mg/kg of Hyperbaric Levobupivacaine 0.5% and Group C will receive 0.3 mg/kg of Hyperbaric Ropivacaine 0.75%. All solutions will be prepared aseptically by the anaesthetist administering the spinal block immediately before injection. The patient will be turned to supine position immediately after injection, the time will be defined as ‘zero’. The principal researchers will not aware about the applying drug.

·       Assessment and monitoring will be done by the investigator who will not be aware of the drugs being administered to the patient.

·       Upper and lower limits of sensory block (analgesia to pinprick using the short bevel end of a 25g intramuscular needle) will be assessed. Caudate limit of sensory block assessment will be S2. The degree of motor block (Modified Bromage Scale: 0-no motor block, 1-inability to raise extended leg, able to bend knee, 2-inability to bend knee, can flex ankle and 3-no movement) will be assessed. Pulse rate and arterial blood pressure will be recorded at 2,5,10,15 and 30 mins and in hourly intervals thereafter.

·       Post operative assessment will be continued in the post operative recovery unit (PACU). Vitals (BP, Pulse rate and Spo2), regression of motor and sensory block and duration of analgesia will be observed and recorded at 30mins intervals until complete regression of motor and sensory block beyond S2 and adverse sequala will be noted and treatment provided. Patients will be encouraged to mobilize carefully under supervision.

 

              PARAMETERS TO BE OBSERVED

·       Pulse rate, systolic, diastolic, mean blood pressure and Spo2 will be recorded at 2, 5, 10, 15 and 30 mins and 1 and 2 hours for the intra operative period

·       Degree of motor block: Degree of motor block will be assessed by Modified Bromage score

                    0-Full movement.

                    1-Inability to raise extended leg, can bend knee.

                    2-Inability to bend the knee but can flex ankle.

                    3-No movements.

·       Duration of sensory block: Defined as the time from intrathecal injection to regression of pinprick sensation to T10 level.

·       Duration of motor block: Defined as the time from intrathecal injection to the regression of motor block to Modified Bromage score 0

·       Adverse effect: Any other adverse effects like hypotension, bradycardia, respiratory depression, drowsiness, nausea, vomiting, pruritis and post Dural puncture headache

S    STUDY VARIABLES: Independent variables                                                     

1.Age

2.Sex

3.BMI

4.Height

5.PT-INR

6.ASA classification

7.Modified Bromage score

8.Comorbidities

9.Intervention

   Bupivacaine, Levobupivacaine, Ropivacaine

 

Dependent Variables

 

1.Heart Rate

2.Blood Pressure

3.Saturation

4.Respiratory Rate

5.Onset

6.Duration

7.Regression

8.Adverse effect

 

INCLUSION CRITERIA:

A. American Society of Anaesthesiologists (ASA) physical status 1 and 2

B. Patient Age 18-65 years.

C. Patient posted for below knee orthopaedic surgery.

D. BMI <30kg/m2

E. Height 4.5 feet to 5.6 feet

EXCLUSION CRITERIA:

A. Patient refusal

B. ASA physical status 3 and 4

C. Immunocompromised patients

D. Local site infection

E. Known allergy to local Anaesthesia

F. Patient’s on anticoagulants medications


EXPECTED OUTCOME OF PROPOSED STUDY

The present study not only will give us a picture of the efficacy of the Hyperbaric Bupivacaine, Levobupivacaine and Ropivacaine after spinal anaesthesia in patients undergoing proximal femur nailing surgery, but will also reflect the intraoperative hemodynamic stability and adverse side effects of the three drugs. Moreover, it will tell us about the choice of local anaesthetic drug for intrathecal anaesthesia in lower limb surgeries.

 

 

 
Close